Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Misusing topical corticosteroids can cause skin darkening and other side effects.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

Apoptosis is crucial for healthy skin and treating skin diseases.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.